Literature DB >> 10768621

A novel presenilin 1 mutation (Leu166Arg) associated with early-onset Alzheimer disease.

M Ezquerra1, C Carnero, R Blesa, R Oliva.   

Abstract

BACKGROUND: Pathogenic mutations in the presenilin 1 (PS1) gene leading to early-onset Alzheimer disease have been described in various populations. The different mutations are not distributed randomly in the PS1 protein but are clustered in some PS1 exons.
OBJECTIVE: To screen the PS1 gene in search of a potential mutation in a Spanish family with early-onset Alzheimer disease.
METHODS: Single-stranded conformational polymorphism and heteroduplex analyses of all exons were used to search for a potential mutation. Subsequent sequencing of the DNA samples with an abnormal heteroduplex pattern was performed to identity the mutation in the sense strand and in the complementary strand.
RESULTS: We found a novel mutation in exon 6 of the PS1 gene at a site that, so far, had not been described as a cluster of mutations. The mutation (an A to C change) causes a substitution of leucine for arginine at position 166 of the PS1 protein and is located adjacent to the transmembrane domain III, where few mutations have been found. In this family, the disease follows an autosomal inheritance pattern with early onset (range, 32-44 years).
CONCLUSION: A novel missense mutation (Leu166Arg) at an atypical site associated with early-onset Alzheimer disease has been identified in a Spanish family.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768621     DOI: 10.1001/archneur.57.4.485

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.

Authors:  Rebecca Radde; Tristan Bolmont; Stephan A Kaeser; Janaky Coomaraswamy; Dennis Lindau; Lars Stoltze; Michael E Calhoun; Fabienne Jäggi; Hartwig Wolburg; Simon Gengler; Christian Haass; Bernardino Ghetti; Christian Czech; Christian Hölscher; Paul M Mathews; Mathias Jucker
Journal:  EMBO Rep       Date:  2006-08-11       Impact factor: 8.807

3.  Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production.

Authors:  Tobias Moehlmann; Edith Winkler; Xuefeng Xia; Dieter Edbauer; Jill Murrell; Anja Capell; Christoph Kaether; Hui Zheng; Bernardino Ghetti; Christian Haass; Harald Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

Review 4.  Chasing genes in Alzheimer's and Parkinson's disease.

Authors:  Aida M Bertoli-Avella; Ben A Oostra; Peter Heutink
Journal:  Hum Genet       Date:  2004-03-04       Impact factor: 4.132

Review 5.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

6.  A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.

Authors:  Vo Van Giau; Jung-Min Pyun; Jeewon Suh; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  BMC Neurol       Date:  2019-08-07       Impact factor: 2.474

7.  Genetic landscape of early-onset dementia in Hungary.

Authors:  Dora Csaban; Anett Illes; Toth-Bencsik Renata; Peter Balicza; Klara Pentelenyi; Viktor Molnar; Andras Gezsi; Zoltan Grosz; Aniko Gal; Tibor Kovacs; Peter Klivenyi; Maria Judit Molnar
Journal:  Neurol Sci       Date:  2022-06-25       Impact factor: 3.830

8.  Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.

Authors:  Celeste Sassi; Rita Guerreiro; Raphael Gibbs; Jinhui Ding; Michelle K Lupton; Claire Troakes; Katie Lunnon; Safa Al-Sarraj; Kristelle S Brown; Chirstopher Medway; Jenny Lord; James Turton; David Mann; Julie Snowden; David Neary; Jeniffer Harris; Jose Bras; Kevin Morgan; John F Powell; Andrew Singleton; John Hardy
Journal:  Neurobiol Aging       Date:  2014-05-02       Impact factor: 4.673

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.